Mrv0541 02231216072D 17 17 0 0 1 0 999 V2000 0.7223 1.0881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7223 0.2631 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.0078 -0.1494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7066 0.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4211 -0.1494 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -2.1356 0.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8501 -0.1494 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.9363 -0.9698 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.7433 -1.1414 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -4.0788 -1.8950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1558 -0.4269 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -4.9762 -0.3407 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.6037 0.1862 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -3.7753 0.9932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4368 -0.1494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1512 0.2631 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4368 -0.9744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 6 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 7 6 1 1 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 9 10 1 6 0 0 0 9 11 1 0 0 0 0 11 12 1 1 0 0 0 11 13 1 0 0 0 0 7 13 1 0 0 0 0 13 14 1 6 0 0 0 2 15 1 0 0 0 0 15 16 1 0 0 0 0 15 17 2 0 0 0 0 M END > DB02321 > drugbank > N[C@@H](CCSC[C@H]1O[C@H](O)[C@@H](O)[C@@H]1O)C(O)=O > InChI=1S/C9H17NO6S/c10-4(8(13)14)1-2-17-3-5-6(11)7(12)9(15)16-5/h4-7,9,11-12,15H,1-3,10H2,(H,13,14)/t4-,5+,6+,7-,9-/m0/s1 > InChIKey=IQFWYNFDWRYSRA-FIJBBSBCSA-N > 7 > 26.681358244091218 > 1 > 5 > 267.077657971 > 0 > C9H17NO6S > 0 > (2S)-2-amino-4-({[(2S,3S,4S,5S)-3,4,5-trihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid > -2.58 > -4.233186655917743 > -0.81 > 267.299 > 0 > 1 > 0 > 11.31516377364693 > 1.8022463307785994 > 9.495582400043908 > 133.24 > 59.488800000000005 > 6 > 1 > 4.10e+01 g/l > (2S)-2-amino-4-({[(2S,3S,4S,5S)-3,4,5-trihydroxyoxolan-2-yl]methyl}sulfanyl)butanoic acid > 0 > DB02321 > experimental > 5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol $$$$